PeptideDB

Sitagliptin fenilalanil hydrochloride 1339954-75-4

Sitagliptin fenilalanil hydrochloride 1339954-75-4

CAS No.: 1339954-75-4

Sitagliptin fenilalanil HCl is a dipeptide aminopeptidase (DPP-4) inhibitor.
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Sitagliptin fenilalanil HCl is a dipeptide aminopeptidase (DPP-4) inhibitor.

Physicochemical Properties


Molecular Formula C25H25CLF6N6O2
Molecular Weight 590.95
Exact Mass 590.163
CAS # 1339954-75-4
Related CAS # Sitagliptin fenilalanil;1339955-03-1
PubChem CID 168265396
Appearance White to off-white solid powder
Hydrogen Bond Donor Count 3
Hydrogen Bond Acceptor Count 11
Rotatable Bond Count 8
Heavy Atom Count 40
Complexity 846
Defined Atom Stereocenter Count 2
SMILES

C(C1=NN=C2CN(CCN21)C(=O)C[C@H](NC(=O)[C@@H](N)CC1C=CC=CC=1)CC1C=C(C(=CC=1F)F)F)(F)(F)F.Cl

InChi Key LZDQVWZJBLFZSN-PXPMWPIZSA-N
InChi Code

InChI=1S/C25H24F6N6O2.ClH/c26-17-12-19(28)18(27)10-15(17)9-16(33-23(39)20(32)8-14-4-2-1-3-5-14)11-22(38)36-6-7-37-21(13-36)34-35-24(37)25(29,30)31;/h1-5,10,12,16,20H,6-9,11,13,32H2,(H,33,39);1H/t16-,20+;/m1./s1
Chemical Name

(2S)-2-amino-N-[(2R)-4-oxo-4-[3-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]-1-(2,4,5-trifluorophenyl)butan-2-yl]-3-phenylpropanamide;hydrochloride
Synonyms

Sitagliptin fenilalanil hydrochloride; 1339954-75-4; Sitagliptin fenilalanil (hydrochloride); HY-147401A; DA-77863; CS-0676211; (2S)-2-amino-N-[(2R)-4-oxo-4-[3-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]-1-(2,4,5-trifluorophenyl)butan-2-yl]-3-phenylpropanamide;hydrochloride
HS Tariff Code 2934.99.9001
Storage

Powder-20°C 3 years

4°C 2 years

In solvent -80°C 6 months

-20°C 1 month

Shipping Condition Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity


Targets DPP-4 (dipeptidyl aminopeptidase 4)
References

[1]. International Nonproprietary Names for Pharmaceutical Substances (INN). WHO Drug Information, Vol. 36, No. 2, 2022.


Solubility Data


Solubility (In Vitro) DMSO: 25 mg/mL (42.30 mM )
Solubility (In Vivo) Solubility in Formulation 1: ≥ 2.08 mg/mL (3.52 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 1.6922 mL 8.4610 mL 16.9219 mL
5 mM 0.3384 mL 1.6922 mL 3.3844 mL
10 mM 0.1692 mL 0.8461 mL 1.6922 mL
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.